PRECISION MEDICINE
AND THE FUTURE
OF GENOMICS
PMFG 2024 SUMMIT

Opening Ceremony

Genomic Newborn Screening

Track-1 Chair: Nicolas Encina
Executive Director, International Consortium on Newborn Sequencing (ICoNS), USA

The Future of Genomics in Medicine

Keynote Speaker: Dr. Robert Green
Director, Genomes2People Research Program, Harvard Medical School-USA

Qatar’s Vision for Newborn Genome Screening: Shaping the Future of Health from the Very Beginning

Speakers:
Dr. Ammira Akil: Head, Genetic and Metabolic Disorders Clinical Research Program, Sidra Medicine, Qatar
Dr. Tawfeg Ben Omran: Division Chief, Genetic and Genomic Medicine – Sidra Medicine, Qatar

Accelerating Rare Disease Diagnosis

Introduction: Dr. Nicola Withers
Associate Director of Market Development, AMEA, Illumina, Australia.
Plenary Speaker: Dr. Zornita Stark
Lead Clinical Geneticist and Senior Research Fellow, Victorian Clinical Genetics Services (VCGS) Melbourne, Australia

The Pivotal Role of Rare Disease Industry in Newborn Genome Sequencing

Dr. Amy Ponte
Director, Global Scientific Affairs & Diagnostics, Specialty Care, Rare Diseases, Sanofi, USA

Global Population Cohorts

Introduction By the Track Chair: Dr. Hamdi Mbarek
Director of Research and Partnerships at Qatar Precision Health Institute

Global Standards and Frameworks in Genomics: The Role of GA4GH in Shaping International Data Sharing and Health Research.

Mr. Peter Goodhand
CEO, Global Alliance for Genomics and Health (GA4GH), Canada

Sidra Medicine’s Role in Precision Medicine and Transforming Clinical Practice and Research in Qatar.

Dr. Younes Mokrab
Head of Medical and Population Genomics and Lead of Neurological Disorders Research Program, Sidra Medicine.

HBKU’s Impact on Advancing Precision Health: Innovations and Contributions

Dr. Markus Wenk
Dean, College of Health and Life Sciences, HBKU

Qatar University’s Role in Advancing Precision Health: Research, Innovation, and Clinical Impact

Dr. Medhat Askar
Associate Vice President for Clinical Affairs, College of Medicine, Qatar University, Doha

UDST Contributions to Bioinformatics in Advancing Precision Health.

Dr. Mohammad Asif Khan
Associate Dean, College of Computing and IT University of Doha For Science and Technology, UDST.

Advancing Precision Medicine in Qatar: The Pioneering Role of Weill Cornell Medicine-Qatar

Dr. Khaled Machaca
Associate dean of research, Weill Cornell Medicine Qatar

Introduction By the Track Chair: Dr. Khalid Fakhro

Chief Research Officer, Sidra Medicine, Qatar

Unraveling Structural Genomic Variation: Insights into Human Biology, Evolution, and Disease.

Dr. Charles Lee
Scientific Director and Professor, the Jackson Laboratory for Genomic Medicine, USA

Talk title: TBD

Dr. Said Ismail
Acting President, Qatar Precision Health Institute (QPHI), Qatar

Leveraging Ancestry Algorithms to Enhance Understanding of Underserved Latin American Populations

Dr. Carlos Bustamante
Founder and CEO, Galatea Bio Inc, USA.

Our Future Health Consortium: Building a Diverse Health Database to Enhance Medical Research and Improve Population Health Outcomes

Dr.  Raghib Ali
CEO, Chief Investigator and Chief Medical Officer, Our Future Health, UKz

Talk Title: Africa Genome

Speaker: TBA

Talk title: TBD

Dr. Xin Jin
Director, the Institute of Precision Health, Beijing Genomics Institute (BGI)Group, China

Talk title: FinnGen Program

Speaker: TBA

All OF US Research Program

Keynote Speaker: Geoff Ginsburg (TBC)
Chief Medical and Scientific Officer, All of Us Research Program, National Institutes of Health, USA

Exhibitors Recognition Dinner

The Spider Exhibition Area

Recognition speech by the Summit’s Chairs

Recognition Light Dinner

Bus pickup for Speakers to the hotel

Implementing Genomics: Bridging Science and Healthcare

Chair: Sonia Davila
Executive Director, Translational Medicine Division, Sidra Medicine, Qatar

Advancing Rapid Genomic Sequencing for Diagnosing and Treating Genetic Diseases in Intensive Care Units

Keynote Speaker: TBC

Ensuring Equity in Genetic Diagnostics: Strategies for Universal Access to Advanced Testing and Personalized Treatments.

Dr. Tan Ee Shien
Head of SingHealth-Duke-NUS Genomic Medicine Centre, Head Genetics Services, KK Women’s and Children’s Hospital, Singapore

TBC

Integrating Genetic Results: Leveraging CLIA-Certified NGS for Rare Disease Discovery and Patient Care

Margaret Harr
Clinical Genetics Counselor, Center for Applied Genomics, Children Hospitall of Philadiliphoa, USA

Talk title: TBD

Dr. Marilyn M. Li
Vice Chief of the Division of Genomic Diagnostics and Director of Cancer Genomic Diagnostics at Children’s Hospital of Philadelphia

Talk title: TBD

Dr. Nancy B. Spinner
Chief of the Division of Genomic Diagnostics at Children’s Hospital of Philadelphia

THE DEBATE
SPONSORED BY DOHA DEBATES
Details TBA

Innovating in Genomics: Journey of a Health Spin-Off – Navigating Regulatory Hurdles, Funding Strategies, and Market Adoption

Chair: TBC
Keynote Speaker: Dr. Gordon Sanghera, CEO and co-founder of Oxford Nanopore Technologies, UK

Panelists: TBA

Evaluating Your Career Choices: Opportunities in Big Pharma vs. Startups and Academia vs. Research Institutes.

Chairs:
Dr. Medhat Askar: Associate Vice President for Clinical Affairs, Qatar Univerity, Qatar .

Motivating Speech From An Emerging Young Scientist
Speaker: Dr. Abdulrahman Al-Subaiey, Postdoctoral Fellow, Immunodysregulation Lab, Sidra Medicine, Qatar.
Panelists:

• Dr. Daniel Ory, Chief Medical Officer, Arbor Bio-USA
• Dr. Rayaz Malik, Professor & Assistant Dean for Clinical Investigations, WCM, Qatar
• Dr. Essam Abdelalim, Principal Investigator, Sidra Medicine

Advancing Healthcare in Qatar: Innovations in Diagnostics, Treatment, and Technology Integration.

Chair: TBD

Talk title: TBD

Dr. Ankit Malhotra
Worldwide Genomics Lead, Public Sector, AWS Health, USA

Advancing Facial Diagnostics: Utilizing Novel Machine Learning Models for Accurate Measurement and Personalized Treatment.

Dr. Mitchell Stotland
Vice Chair, Department of Surgery, Division Chief of Plastic and Craniofacial Surgery, Sidra Medicine, Qatar

Harnessing AI Technologies and Expertise to Propel Human Health: Seizing Opportunities for Innovation and Confidence

Dr. Joanne Hackett
Vice President Health System Services and Head of Genomic and Precision Medicine at, IQVIA, UK.

NVIDIA Presentation

Talk title: TBD

Speaker: TBD

Dell Technologies

Unleashing Healthcare Potential: Advancing Decision-Making Through AI-Powered Analysis

Abhi Verma
Chief Technology Officer, SOPHiA GENNETICS, Switzerland

Gala Dinner

Expert Forum on Custom-Made Therapies and Clinical Trials

Chair: TBD

N-OF-1 Therapeutics

Keynote Speaker: TBD

Featured Keynote Speaker Genomically-Informed Clinical Trials

Dr. Hakon Hakonarson
Director of the Center for Applied Genomics (CHOP) and professor of Pediatrics University of Pennsylvania, USA.

Revolutionizing Medicine: The Promise of RNAi Therapeutics

Speaker: Dr. Wan Yue
Deputy Executive Director of the Genome Institute of Singapore, A*STAR, Singapore

Featured Keynote Lecture: From Stem Cell and Cellular Therapies for Severe Disease Conditions to Disease Prevention and Reversal to Prolong Healthspan

Chair: Dr. Matthias Von Herrath, Vice President and Senior Medical Officer, Novo Nordisk and University of Miami, USA
Keynote Speaker: Dr. Camillo Recordi
Director, Cell Transplant Center, University of Miami, USA.

Chair: Dr. Matthias Von Herrath, Vice President and Senior Medical Officer, Novo Nordisk and University of Miami, USA
Arresting Type 1 Diabetes: Insights and Innovations from Leading Experts and Clinical Trials.
Keynote Address: Dr. Chantal Mathieu
President of European Association for the Study of Diabetes (EASD), Belgium.

Early Detection and Screening Strategies for Type 1 Diabetes

Dr. Emmanuele Bosi
Professor of Endocrinology, Università Vita-Salute San Raffaele; Director, TrialNet Clinical Center, San, Italy.

The Development and Evaluation of Innovative Interventions and Collaborative Testing

Dr. Manuela Battaglia
Managing Director of The INNODIA iVZW, Clinical Trial Platform of Type 1 Diabetes, Italy.

Featured Keynote Highlights: Novel Therapies for Type 1 Diabetes

Chair: Chantal Mathieu, President of European Association for the Study of Diabetes (EASD), Belgium
Keynote: Dr. Matthias Von Herrath
Vice President and Senior Medical Officer, Novo Nordisk and University of Miami, USA

Chair: Dr. Hakon Hakonarson
Director of the Center for Applied Genomics (CHOP) and professor of Pediatrics University of Pennsylvania, USA.

Keynote Address
Talk title: TBD

Keynote Speaker: Dr. James Wilson
Rose H. Weiss Professor and Director, Orphan Disease Center, University of Pennsylvania, USA.

Ex-Vivo Gene Editing:
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and Transfusion Dependent β-Thalassemia

Dr. Haydar Frangoul
Director, Pediatric Stem Cell Transplant Program, Tristar Centennial Children’s Hospital, Nashville, Tennessee, USA.

In-Vivo Gene Editing:
Development of ABO-101, A Novel Gene Editing Therapy for Primary Hyperoxaluria Type 1

Dr. Daniel Ory
Chief Medical Officer, Arbor Biotech, Cambridge, MA, USA

SUMMARY OF THE EVENT, CLOSING REMARKS, AWARDS and SPONSORS RECOGNITION